Squarepoint
DXCM icon

Squarepoint’s DexCom DXCM Stock Holding History

Squarepoint’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,200
Closed -$1.61M – 4413
2025
Q4 		$1.61M Sell
24,200
-23,600
-49% -$1.53M ﹤0.01% 2210
2025
Q3 		$3.22M Sell
47,800
-10,500
-18% -$831K ﹤0.01% 1736
2025
Q2 		$5.09M Sell
58,300
-83,000
-59% -$6.51M 0.01% 1452
2025
Q1 		$9.65M Sell
141,300
-275,400
-66% -$22.5M 0.01% 1047
2024
Q4 		$32.4M Buy
416,700
+153,700
+58% +$11.4M 0.03% 535
2024
Q3 		$17.6M Buy
263,000
+190,200
+261% +$15.6M 0.03% 651
2024
Q2 		$8.25M Buy
72,800
+41,100
+130% +$5.2M 0.01% 1045
2024
Q1 		$4.4M Sell
31,700
-400
-1% -$50.3K 0.01% 1537
2023
Q4 		$3.98M Sell
32,100
-32,600
-50% -$3.33M 0.01% 1538
2023
Q3 		$6.04M Buy
64,700
+61,600
+1,987% +$6.94M 0.01% 1060
2023
Q2 		$398K Sell
3,100
-13,000
-81% -$1.57M ﹤0.01% 2779
2023
Q1 		$1.87M Sell
16,100
-46,100
-74% -$5.16M 0.01% 1457
2022
Q4 		$7.04M Sell
62,200
-14,300
-19% -$1.57M 0.03% 669
2022
Q3 		$6.16M Buy
76,500
+7,800
+11% +$661K 0.03% 638
2022
Q2 		$5.12M Buy
68,700
+13,900
+25% +$1.27M 0.03% 672
2022
Q1 		$7.01M Sell
54,800
-37,600
-41% -$4.11M 0.03% 574
2021
Q4 		$12.4M Hold
92,400
– – 0.03% 456
2021
Q3 		$12.6M Buy
92,400
+27,600
+43% +$3.48M 0.04% 429
2021
Q2 		$6.92M Buy
64,800
+3,600
+6% +$346K 0.03% 601
2021
Q1 		$5.5M Buy
+61,200
New +$5.74M 0.03% 587

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Squarepoint's DXCM Position: Q1 2026 in Review

Squarepoint reduced its DexCom (DXCM) stake by 54% in Q1 2026, selling an estimated $95.6M and leaving 1,154,441 shares worth $72.5M. The position accounts for 0.09% of the portfolio, ranked #228.

Squarepoint first reported a position in DXCM in Q2 2015 and has held it in 35 quarters since. The position peaked at $168M in Q4 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Squarepoint held 1,154,441 shares of DexCom worth $72.5M as of Q1 2026.
  • Squarepoint sold 1,373,007 DexCom shares in Q1 2026, an estimated $95.6M.
  • DexCom made up 0.09% of Squarepoint's portfolio in Q1 2026, its #228 holding.
  • Squarepoint first reported a position in DexCom in Q2 2015 and has held it in 35 quarters since.
  • Squarepoint's DexCom position peaked at $168M in Q4 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.